Extracellular nucleotides, cartilage stress, and calcium crystal formation

Current Opinion in Rheumatology

Volumn 15, Issue 3, 2003, Pages 315-320

  Graff, Ronald D ^a   Picher, Maryse ^a   Lee, Greta M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ALKALINE PHOSPHATASE; CALCIUM; MATRIX PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOTIDE; PHOSPHATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE; PYROPHOSPHATE;

CARTILAGE CELL; CARTILAGE MATRIX; CRYSTALLIZATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; EXTRACELLULAR SPACE; MECHANICAL STIMULATION; MINERALIZATION; NUCLEOTIDE METABOLISM; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; STRESS;

ANIMALS; CALCINOSIS; CALCIUM PYROPHOSPHATE; CARTILAGE, ARTICULAR; CHONDROCALCINOSIS; CHONDROCYTES; CRYSTALLIZATION; EXTRACELLULAR SPACE; HUMANS; MALE; NUCLEOTIDES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0038070145     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200305000-00021     Document Type: Review

References (72)

1. Mitrovic DR, Stankovic A, Iriarte-Borda O, et al.: The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol 1988, 15:633-641.
2. Derfus BA, Kurian JB, Butler JJ, et al.: The high prevalence of pathologic calcium crystals in preoperative knees. J Rheumatol 2002, 29:570-574.
3. Ryan LM, Rachow JW, McCarty DJ: Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991, 18:716-720.
4. Park W, Masuda I, Cardenal-Escarcena A, et al.: Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. J Rheumatol 1995, 23:665-671.
5. Hatori M, Teixeira CC, Debolt K, et al.: Adenine nucleotide metabolism by chondrocytes in vitro: role of ATP in chondrocyte maturation and matrix mineralization. J Cell Physiol 1995, 165:468-474.
6. Graft RD, Lazarowski ER, Banes AJ, et al.: ATP release by mechanically loaded porcine chondrons in pellet culture. Arthritis Rheum 2000, 43:1571-1579.
7. Bodin P, Burnstock G: Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol 2001, 38:900-908.
8. Hazama A, Shimizu T, Ando-Akatsuka Y, et al.: Swelling-induced, CFTR-independent ATP release from a human epithelial cell line: lack of correlation with volume-sensitive CI(-) channels. J Gen Physiol 1999, 114:525-533.
9. Roman RM, Feranchak AP, Davison AK, et al.: Evidence for Gd(3+) inhibition of membrane ATP permeability and purinergic signaling. Am J Physiol 1999, 277:G1222-1230.
10. al-Awqati Q: Regulation of ion channels by ABC transporters that secrete ATP. Science 1995, 269:805-806.
11. Roman RM, Wang Y, Lidofsky SD, et al.: Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 1997, 272:21970-21976.
12. Cotrina ML, Lin JHC, Alves-Rodrigues A, et al.: Connexins regulate calcium signaling by controlling ATP release. Proceedings of National Academy of Sciences 1998, 95:15735-15740.
13. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000, 289:265-270.
14. Ryan LM: The ank gene story. Arthritis Res 2001, 3:77-79.
15. Johnson K, Van Etten D, Terkeltaub R: ANK and PC-1 regulate cartilage matrix calcification by synergistically controlling extracellular Ppi (abstract). Arthr Rheum 2001, 44:S162.
16. Rosenthal AK, Ryan LM: Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage. Mech Ageing Dev 1994, 75:35-44.
17. Lee RB, Wilkins RJ, Razaq S, et al.: The effect of mechanical stress on cartilage energy metabolism. Biorheology 2002, 39:133-143. This report describes the depletion of intracellular ATP with prolonged static compression.
18. Johnson K, Jung A, Murphy A, et al.: Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000, 43:1560-1570.
19. Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001, 281:C1-C11.
20. Zimmermann H, Beaudoin AR, Bollen M, et al.: Ecto-ATPases and related ectonucleotidases. Shaker Publications 2000:1-20.
21. Donaldson SH, Picher M, Boucher RC: Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 2002, 26:209-215.
22. Lazarowski ER, Homolya L, Boucher RC, et al.: Identification of an ectonucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists. J Biol Chem 1997, 272:20402-20407.
23. Kubler D, Pyerin W, Kinzel V: Assays of cell surface protein kinase: importance of selecting cytophilic substrates. Eur J Cell Biol 1982, 26:306-309.
24. Aeschlimann D, Thomazy V: Protein crosslinking in assembly and remodeling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000, 41:1-27.
25. Clair T, Krutzsch HC, Liotta LA, et al.: Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides. Biochem Biophys Res Commun 1997, 236:449-454.
26. Bollen M, Gijsbers R, Ceulemans H, et al.: Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000, 35:393-432.
27. Johnson K, Hashimoto S, Lotz M, et al.: upregulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001, 44:1071-1081.
28. Johnson K, Vaingankar S, Chen Y, et al.: Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999, 42:1986-1997.
29. Lotz M, Rosen F, McCabe G, et al.: Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci USA 1995, 92:10364-10368.
30. Johnson K, Pritzker K, Coding J, et al.: The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. J Rheumatol 2001, 28:2681-2691.
31. Derfus B, Kranendonk S, Camacho N, et al.: Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998, 63:258-262.
32. Masuda I, Hamada J, Haas AL, et al.: A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995, 95:699-704.
33. Lorenzo P, Neame P, Sommarin Y, et al.: Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem 1998, 273:23469-23475.
34. Cardenal A, Masuda I, Haas A, et al.: Specificity of a porcine 127-kd nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996, 39:245-251.
35. Hirose J, Masuda I, Ryan LM: Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum 2000, 43:2703-2711.
36. Hirose J, Ryan LM, Masuda I: upregulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 2002, 46:3218-3229. This study compares the expression of ectoenzymes and ANK with NTPPPH and PPi elaboration in normal and osteoarthritic human cartilage with and without CPPD crystals
37. Yeung G, Mulero JJ, McGowan DW, et al.: CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart. Biochemistry 2000, 39:12916-12923.
38. Braun N, Sevigny J, Robson SC, et al.: Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci 2000, 12:4357-4366.
39. Miao D, Scutt A: Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 2002, 50:333-340. This study demonstrates that tissue nonspecific alkaline phosphatase (TNAP) is localized on plasma membranes and matrix vesicles in human cartilage.
40. Rees JA, Ali SY: Ultrastructural localisation of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1988, 47:747-753.
41. Kouri JB, Aguilera JM, Reyes J, et al.: Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000, 27:1005-1019.
42. Harada M, Udagawa N, Fukasawa K, et al.: Inorganic pyrophosphatase activity of purified bovine pulp alkaline phosphatase at physiologic pH. J Dent Res 1986, 65:125-127.
43. Xu Y, Cruz TF, Pritzker KP: Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals. J Rheumatol 1991, 18:1606-1610.
44. Yegutkin GG, Henttinen T, Samburski SS, et al.: The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. Biochem J 2002, 367:121-128.
45. Buxton IL, Kaiser RA, Oxhorn BC, et al.: Evidence supporting the Nucleotide Axis Hypothesis: ATP release and metabolism by coronary endothelium. Am J Physiol Heart Circ Physiol 2001, 281:H1657-1666.
46. Graft RD, Lazarowski ER, Lee GM: Interconversion of extracellular nucleotides by ectonucleoside diphosphokinase on porcine articular chondrocytes. Trans Ortho Res Soc 2001, 26:405.
47. Wortmann RL, Ryan LM: Biological variation of rabbit chondrocyte 5′nucleotidase. Proc Soc Exp Biol Med 1983, 173:349-354.
48. Mistry D, Chambers M, Mason R: Increased Adenosine Production in Murine Osteoarthritis and Adenosine Receptor Mediated Signaling in Murine Chondrocytes. Trans Ortho Res Soc 2001, 26:653.
49. Benton HP, MacDonald MH, Tesch AM: Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes. Am J Vet Res 2002, 63:204-210.
50. Tesch AM, MacDonald MH, Kollias-Baker C, et al.: Chondrocytes respond to adenosine via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthritis Cartilage 2002, 10:34-43. This article demonstrates the activation of chondrocyte A2 receptors by adenosine and the subsequent degradation of adenosine by endogenous extracellular enzymes.
51. Ryan LM, Kurup IV, Cheung HS: Transduction mechanisms of procine chondrocyte inorganic pyrophosphate elaboration. Arthritis Rheum 1999, 42:555-560.
52. Todorov LD, Mihaylova-Todorova S, Westfall TD, et al.: Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 1997, 387:76-79.
53. Mihaylova-Todorova ST, Todorov LD, Westfall DP: Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated was deferens during nerve stimulation: evidence for a soluble ectonucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5′-nucleotidase-like AMPase. J Pharmacol Exp Ther 2002, 302:992-1001.
54. Yegutkin G, Bodin P, Burnstock G: Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 2000, 129:921-926.
55. Lee GM, Seidel H, Tchivilev I, et al.: Mechanical stimulation increases ecto-ATPase activity (abstract). Mol Biol Cell 2002, 13(S):366.
56. Rosenthal AK, Derfus BA, Henry LA: Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 1997, 40:966-970.
57. Rosenthal AK, Masuda I, Gohr CM, et al.: The transglutaminase, Factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 2001, 9:578-581.
58. Johnson K, Hashimoto S, Lotz M, et al.: Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001, 159:149-163.
59. Summey BT Jr., Graft RD, Lai TS, et al.: Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res 2002, 20:76-82. This study reports the inhibition of tissue transglutaminase activity in human articular cartilage explants by GTP, demonstrating similar regulation of tTG in vitro and in vivo, and suggesting that nucleotides released by chondrocytes may control matrix cross-linking.
60. Le M, Gohr CM, Rosenthal AK: Transglutaminase participates in the incorporation of latent TGFbeta into the extracellular matrix of aging articular chondrocytes. Connect Tissue Res 2001, 42:245-253.
61. Johnson K, Van Etten D, Terkeltaub R: IL-1-induced activation of the tissue transglutaminase isozyme is central to matrix calcification by articular chondrocytes. Arthr Rheum 2002, 45:S371. This article reports that IL-1 fails to stimulate matrix calcification in chondrocytes from tissue transglutaminase-null mice, and that over-expression of tTG promotes mineralization.
62. Lai TS, Slaughter TF, Peoples KA, et al.: Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 1998, 273:1776-1781.
63. Lai TS, Slaughter TF, Koropchak CM, et al.: C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem 1996, 271:31191-31195.
64. Nakano S, Ikata T, Kinoshita I, et al.: Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1999, 17:161-170.
65. Redegeld FA, Caldwell CC, Sitkovsky MV: Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol Sci 1999, 20:453-459.
66. Zhu X, Luo C, Ferrier JM, et al.: Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro. Biochem J 1997, 323 (Pt 3):637-643.
67. Steitz SA, Speer MY, McKee MD, et al.: Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002, 161:2035-2046. This report signifies that osteopontin, an ECM molecule and endogenous phosphoprotein, can regulate calcium crystal deposition and growth.
68. Hunter GK, Hauschka PV, Poole AR, et al.: Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996, 317 (Pt 1):59-64.
69. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000, 275:20197-20203.
70. Attur MG, Dave MN, Stuchin S, et al.: Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 2001, 44:578-584.
71. Schwab W, Gavlik JM, Beichler T, et al.: Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta 1-integrin. Histochem Cell Biol 2001, 115:317-323.
72. Westfall DP, Todorov LD, Mihaylova-Todorova ST: ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther 2002, 303:439-444.